ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 354

Increased Vascular Wall Inflammation in Patients with Active Rheumatoid Arthritis As Measured By an 18F-FDG-PET/CT Scan

Rabia Agca1,2, Alper M. van Sijl2,3, Yvo M. Smulders4, Alexandre E. Voskuyl5, Connie J. van der Laken6, Ronald Boellaard7, Karel-Jan D.F. Lensen8 and Michael T. Nurmohamed1,2, 1Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 2VU University Medical Center, Amsterdam, Netherlands, 3[email protected], Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 4Internal Medicine, VU University Medical Center, Amsterdam, Netherlands, 5Department of Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 6Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 7Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands, 8Department of Internal Medicine, VU University Medical Center, Amsterdam, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: 18FDG PET/CT scan, Cardiovascular disease, inflammation and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects: Novel Biomarkers and Other Measurements of Disease Activity

Session Type: Abstract Submissions (ACR)

Background/Purpose : Patients with rheumatoid arthritis (RA)  have an elevated risk of developing cardiovascular  disease (CVD). Like active RA, atherosclerosis is an inflammatory process. There are indications that aortic inflammation in atherosclerosis can be detected on an 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography scan (18F-FDG-PET/CT).

 

Objective: To quantify 18F-FDG uptake in large arteries of RA patients using PET/CT, as potential reflection of vascular wall inflammation in areas of atherosclerosis, and its association with disease activity in patients with RA as compared to controls.

 

Methods : 18F-FDG-PET/CT scan was performed in patients with active RA (DAS28 > 4.0; n=29) and in controls with osteoarthritis (n=11). Semi-quantitative FDG-uptake was determined by calculation of the mean standardized uptake value (SUV) and tissue-to-background ratio (TBR) using 18F-FDG activity in the vena cava as background. One volume of interest (VOI) of an arterial segments with maximum 18F-FDG uptake was used for SUV calculation (focal arterial uptake). Total arterial uptake was estimated by using the mean of all focal arterial uptakes in all arteries.

Results : Focal as well as total arterial uptake of 18F-FDG was the highest in patients with RA. SUV was significantly higher in RA for the thoracic aortic tract, the abdominal aorta and the femoral arteries as compared to OA controls. C-reactive protein was associated with an increased total arterial uptake as well as an increased focal arterial uptake in the thoracic aortic tract, the abdominal aorta, the iliac arteries and the femoral arteries. DAS28 >2,6 was also correlated to total arterial uptake and uptake in the thoracic aortic tract, the abdominal aorta and the iliac arteries. There were no significant differences in TBR between RA and OA.

 

eular3

Conclusion: Increased focal vascular wall uptake of 18F-FDG as sign of vascular inflammation was found in several arterial segments of RA patients. C-reactive protein and clinical RA activity were correlated with 18F-FDG uptake in most of these arteries. Overall, total arterial uptake was higher in RA patients and it was correlated with C-reactive protein and disease activity. The lack of differences in TBR measurements requires further study.

 


Disclosure:

R. Agca,
None;

A. M. van Sijl,
None;

Y. M. Smulders,
None;

A. E. Voskuyl,
None;

C. J. van der Laken,
None;

R. Boellaard,
None;

K. J. D. F. Lensen,
None;

M. T. Nurmohamed,

AbbVie,

2.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-vascular-wall-inflammation-in-patients-with-active-rheumatoid-arthritis-as-measured-by-an-18f-fdg-petct-scan/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology